Alterity Therapeutics Limited (ATHE) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q2'26 | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q2'23 | Q4'22 | Q2'22 | Q4'21 | Q2'21 | Q4'20 | Q2'20 | Q4'19 | Q2'19 | Q4'18 | Q2'18 | Q4'17 | Q2'17 | Q4'16 |
|---|
| Cash from Operations | -10.43M | -2.36M | -8.36M | -8.11M | -4.49M | -10.11M | -5.16M | -256K | -8.67M | -10M | -7.33M | -6.85M | -2.59M | -6.73M | -7.22M | -5.07M | -1.17M | -5.24M | -620.95K | -39.99K |
| Operating CF Margin % | - | -61.45% | -520.55% | -382.85% | -236.49% | -660.65% | -216.23% | -9.26% | -367.58% | -407.11% | -389.22% | 369% | -139.37% | -266.69% | -297.62% | -307.73% | -79.37% | -419.04% | -32.62% | -1.96% |
| Operating CF Growth % | -24.72% | 70.96% | -85.98% | 19.78% | 12.87% | -3849.69% | 40.51% | 97.44% | -18.3% | -46.08% | -183.5% | -1.67% | 64.2% | -32.74% | -515.84% | 3.27% | -88.85% | -13014.91% | 77.82% | - |
| Net Income | -9.44M | -3.16M | -7.17M | -12.62M | -4.25M | -3.9M | -8.03M | -6.26M | -6.58M | -5.21M | -8.56M | -7.82M | -5.64M | -7M | -5.34M | -4.65M | -3.62M | -3.89M | -3.65M | -4.87M |
| Depreciation & Amortization | 56.83K | 42.58K | 47.98K | 73.61K | 48.24K | 35.31K | 50K | 22.68K | 31.54K | 30.65K | 35.63K | 55.21K | 57.22K | 15.02K | 14.68K | 12.47K | 9.32K | 10.81K | 10.52K | 9.62K |
| Stock-Based Compensation | 0 | -141.34K | 1.12M | 569.66K | 312.29K | 322.2K | 627.22K | 630.82K | 875.3K | 307.04K | 1.58M | -12.02K | 0 | 10.05K | 79.09K | 602.15K | 162.39K | 24.46K | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 1.05M | 6.24M | -2.29M | 0 | 169.2K | 1.17M | 0 | 807.05K | 1.18M | 547.74K | -871.59K | 584.8K | 0 | 0 |
| Other Non-Cash Items | 2.22M | -5.8M | -298.05K | 723.93K | -6.12M | -10.11M | 3.26M | -4.43M | -1.22M | -10M | 4.3M | -128.89K | -134.09K | -174.08K | 346.07K | 575.23K | 865.7K | -25.64K | -174.47K | 415.3K |
| Working Capital Changes | -3.26M | 3.44M | -2.01M | 3.14M | 1.62M | -2.9M | -2.12M | 3.54M | -1.78M | -2.41M | -1.37M | 1.06M | 3.13M | 413.56K | -2.32M | -1.61M | 1.41M | -1.36M | 3.19M | 4.41M |
| Change in Receivables | -2.85M | 4.32M | -4.21M | 1.94M | 2.79M | -1.09M | -2.35M | 1.54M | -1.98M | -1.87M | -1.92M | 1.82M | 2.95M | 760.07K | -2.44M | -1.7M | 1.58M | -1.19M | 2.94M | 4.46M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -961.1K | 0 | 0 | 0 | 0 | 0 | -634.86K | 1.97M | 631.65K | 0 | 255.5K | -554.79K | -93.78K | 87.06K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | 7.36M | -7.5M | 0 | -722 | -1K | -26.58K | -4.88K | -89K | -2.56K | -10.47K | -2.49K | -9.24K | -7.5K | -4K | -3.27K | -15.08K | -3.34K | -5.76K | -22.16K | 903 |
| Capital Expenditures | 0 | 0 | 0 | 278 | -2K | 2.57K | -4.88K | -89K | -2.56K | -10.47K | -2.49K | -9.24K | -7.5K | -4K | -3.27K | -59.07K | -3.34K | -5.76K | -22.16K | -571 |
| CapEx % of Revenue | - | - | 0% | 0.01% | 0.11% | 0.17% | 0.2% | 3.22% | 0.11% | 0.43% | 0.13% | -0.5% | 0.4% | 0.16% | 0.13% | 3.58% | 0.23% | 0.46% | 1.16% | 0.03% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -1K | 1K | -29.15K | 0 | 0 | 2.56K | 0 | 0 | 0 | 0 | 0 | 0 | 43.99K | 0 | 0 | 0 | 1.47K |
| Cash from Financing | 18.85M | 25.24M | 369.32K | 8.17M | 970K | -12.76K | -108.9K | -29K | -23K | 36.65M | 34.17M | 3.3M | 3K | 11.24M | 142.95K | -69.84K | -37.84K | -5.2K | -154.36K | -28.59M |
| Debt Issued (Net) | 0 | -127.1K | -68.25K | -10.37K | -54.79K | -32.15K | -27.77K | -34.51K | -23.75K | -58.29K | -24.25K | 0 | -45.33K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 18.91M | 27.17M | 398.64K | 94.68K | 1.13M | 5.83K | -158 | 40 | 40 | 39.2M | 24.71M | 3.78M | 94.51K | 12.58M | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -65.03K | -1.81M | 38.92K | 8.08M | -101.21K | 13.56K | -80.97K | 5.47K | -245.25K | -2.49M | 34.19M | -479.7K | -46.18K | -1.34M | 142.95K | -69.84K | -37.84K | -5.2K | -154.36K | -28.59M |
| Net Change in Cash | 16.6M | 15.2M | -4.75M | 318.46K | -4.39M | -25.34M | -6.51M | 2.17M | -4.33M | 28.08M | 25.85M | -1.19M | 1.49M | 5.49M | -3.43M | -22.32M | -911.88K | -31.57M | -125.89K | -29.29M |
| Free Cash Flow | 0 | -2.36M | -8.36M | -8.11M | -4.86M | -6.2M | -5.16M | -345K | -8.67M | -17.33M | -7.33M | -6.85M | -2.59M | -6.74M | -7.23M | -5.13M | -1.18M | -5.25M | -643.11K | -40.56K |
| FCF Margin % | - | -61.45% | -520.55% | -382.84% | -255.9% | -405.4% | -216.43% | -12.48% | -367.69% | -705.46% | -389.35% | 369.49% | -139.78% | -266.85% | -297.75% | -311.31% | -79.6% | -419.5% | -33.78% | -1.99% |
| FCF Growth % | 100% | 70.96% | -71.87% | -30.72% | 5.8% | -1698.45% | 40.47% | 98.01% | -18.3% | -152.79% | -182.78% | -1.75% | 64.11% | -31.29% | -514.37% | 2.25% | -82.86% | -12844.46% | 77.04% | - |
| FCF per Share | - | -0.19 | -0.94 | -0.77 | -1.17 | -1.53 | -1.28 | -0.09 | -2.16 | -4.99 | -3.32 | -4.46 | -1.79 | -5.83 | -8.08 | -5.77 | -1.32 | -5.88 | -0.72 | -0.05 |
| FCF Conversion (FCF/Net Income) | 1.10x | 0.47x | 1.17x | 0.64x | 0.69x | 1.75x | 0.64x | 0.04x | 1.32x | 1.48x | 0.86x | 0.88x | 0.46x | 0.96x | 1.35x | 1.09x | 0.32x | 1.35x | 0.17x | 0.01x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |